Product Description
Reference Standards &Impurity
AI Product Description
*The following content is generated by AI and is for reference only.
Bupivacaine is a widely utilized long-acting amide local anesthetic belonging to the piperidine class of compounds. Its molecular formula is C18H28N2O, and it is uniquely identified by the CAS registry number 38396-39-3. First synthesized in the early 1960s, this medication has become a cornerstone in modern clinical practice for providing effective pain relief during surgical procedures and managing acute or chronic pain conditions.
The primary mechanism of action involves the reversible blockade of voltage-gated sodium channels on nerve cell membranes. By inhibiting the influx of sodium ions, Bupivacaine prevents the generation and conduction of nerve impulses, thereby producing a profound loss of sensation in a specific area without affecting consciousness. This property makes it indispensable for regional anesthesia techniques, including epidural blocks, spinal anesthesia, peripheral nerve blocks, and infiltration anesthesia. It is particularly valued for its prolonged duration of action compared to shorter-acting agents like lidocaine, often lasting several hours depending on the concentration and site of administration.
Clinically, Bupivacaine is extensively employed in obstetrics for labor analgesia, in orthopedics for post-operative pain management, and in various minor surgical interventions. It is available in multiple formulations, such as plain solutions, liposomal encapsulated versions for extended release, and combination products with epinephrine to prolong its effect through vasoconstriction. While highly effective, careful dosing is critical due to the potential risk of systemic toxicity, which can manifest as central nervous system excitation followed by depression, or severe cardiotoxicity if accidentally injected intravascularly. The drug is typically administered under strict medical supervision to ensure patient safety.
Beyond standard medical applications, research continues into novel delivery systems to enhance efficacy while minimizing adverse effects. Despite the emergence of newer anesthetics, Bupivacaine remains a gold standard in many therapeutic scenarios due to its reliable profile and extensive clinical history. Its versatility across diverse medical specialties underscores its enduring importance in the pharmaceutical landscape, serving millions of patients annually to facilitate pain-free recovery and surgical success.